Browsing Category
Pharma Industry News
4723 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Is NS002 the catalyst that could finally modernize emergency anaphylaxis treatment? (NYSE: NSRX)
Nasus Pharma Ltd. advances NS002 toward pivotal trials, signaling a potential shift in anaphylaxis treatment. Find out what this means for the market.
Alembic Pharmaceuticals (APLLTD) wins FDA final approval for Paroxetine Extended-Release Tablets
Alembic Pharmaceuticals (APLLTD) wins USFDA final approval for Paroxetine ER 12.5 mg tablets. Read what it means for the US generic pipeline and investor outlook.
ABIONYX Pharma (ABNX) achieves sphingomyelin manufacturing breakthrough to advance CER-001 sepsis program
ABIONYX Pharma triples CER-001 sphingomyelin yield with proprietary synthesis, advancing its sepsis programme. Read the full strategic analysis.
Avacta Group (AIM: AVCT) closes oversubscribed £10m placing at 9.35% discount as AVA6103 enters clinical dosing
Avacta Group (AIM: AVCT) completes an oversubscribed £10m equity placing at 63p ahead of late-2026 AVA6103 Phase 1 data. Read the full analyst breakdown.
Aging biotech just got a real skin test and Rubedo Life Sciences may have passed the first one
Rubedo Life Sciences posted early RLS-1496 skin trial data. Read why these Phase 1 results could matter for dermatology, aging science, and biotech.
Can deeper university alliances help Propanc Biopharma, Inc. stabilize its clinical transition?
Propanc Biopharma expands university research partnerships as it enters human trials. Discover what this signals for strategy, risk, and investors.
Biocytogen just stacked two cancer bets in three days. Is its platform strategy starting to compound?
Biocytogen’s NEOK002 IND clearance and Moonlight Bio deal highlight a platform-led oncology strategy. Read what it means for growth and sentiment.
SK pharmteco alliance with Prozomix reflects rising CDMO demand for enzyme-driven synthesis platforms
SK pharmteco Inc. and Prozomix partner to scale biocatalysis for greener drug manufacturing. Discover what this means for global pharma supply chains.
Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity
Oxford Biomedica (OXB) reports 33% revenue growth and first EBITDA profit in 2025. BMS CAR-T supply deal and Durham, NC facility acquisition reshape its CDMO strategy. Read more.
Insilico Medicine just doubled down on CNS with Tenacia. Here’s why that matters now.
Insilico Medicine has expanded its Tenacia CNS partnership in a deal worth up to $94.75 million. Read what it signals for AI drug discovery now.